longevitywatch
← All podcasts

Lifespan

hosted by David Sinclair

We tested 62 claims from Lifespan against the research. 9 held up, 4 did not, and the rest are partly true or still too early to judge.

David Sinclair: who he is, what he sells, where he stands →

What a speaker claims elsewhere is on their own profile.

We only test the claims that can be checked, not everything that is said. This is not a ranking.

David Sinclair · hosts Lifespan

professor of genetics and aging researcher at Harvard Medical School · Who he is, what he sells, where he stands →

Partly
“Polyphenols from colourful plant-based foods, such as fisetin, quercetin and resveratrol, can boost metabolism.”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with caution
Research shows that polyphenols such as resveratrol and quercetin do indeed influence energy metabolism, fat storage and energy expenditure. One human study shows that resveratrol produces metabolic changes in obese men that resemble the effects of caloric restriction. For most polyphenols, however, the evidence comes largely from cell studies and animal research, and human studies are still largely absent or limited. Fisetin is not specifically addressed in these studies, and the claim that polyphenols 'boost' metabolism is too simplistic: some substances actually lower resting metabolism, while others appear to increase energy expenditure, depending on the substance and the context.
Partly
“People with Laron syndrome have very low IGF-1 levels due to a defective growth hormone receptor, and develop cancer and diabetes significantly less often”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
The claim that people with Laron syndrome have very low IGF-1 levels due to a defective growth hormone receptor and develop remarkably little cancer and diabetes points in the right direction: research into growth hormone activity does indeed suggest that lower activity in later life may be beneficial for cancer risk. However, the claim presents this as an established fact about this specific group, whereas the available research in humans has not yet been demonstrated unequivocally. The link to diabetes is likewise not firmly established in the underlying research. The claim therefore goes beyond what the evidence currently supports.
✓ Holds up
“Inhibiting the NLRP3 inflammasome extends the lifespan of mice”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Two studies show that mice without a functioning NLRP3 inflammasome, or mice given a compound that blocks the NLRP3 inflammasome, lived longer than mice without that intervention. This applies to normally ageing mice (see scientific article 31625260), to mice with obesity induced by a high-fat diet (see scientific article 31975052) and to mice with an accelerated ageing syndrome (see scientific article 34448355). The claim concerns mice and the evidence was collected exclusively in mice, which means the claim is correct as stated.
✓ Holds up
“Treatment with the peptide FOXO4-DRI rejuvenates mice suffering from a condition involving accelerated ageing”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
The research shows that FOXO4-DRI improves fitness, coat density and kidney function in mice that have been genetically modified to age at an accelerated rate. This is because the compound triggers senescent cells to destroy themselves. This is precisely what the claim states: rejuvenating effects in mice with accelerated ageing. The claim explicitly states that it concerns mice, and the evidence was indeed gathered in mice, so the claim does not go beyond the available evidence.
Partly
“Bremelanotide stimulates sexual desire and can be used to treat low libido in women.”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Bremelanotide is well documented as a drug that can increase sexual desire in women, and several completed phase 3 trials in women with hypoactive sexual desire disorder support this picture. The claim is therefore broadly correct. What is missing is an important nuance: bremelanotide is not routinely available in the Netherlands, which means the threshold for its use in practice is considerably higher than the claim suggests.
Partly
“Mosquitoes that ingest the protein IGF-1 through blood can live up to 23% longer.”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research on the malaria mosquito Anopheles stephensi shows that a low dose of IGF-1 ingested through a blood meal extended the average lifespan of mosquitoes by 23% compared to a control group. The claim is therefore correct for that specific mosquito species and that specific dose. However, a second study on the same species adds nuance: only the low dose of IGF-1 extended lifespan, while the high dose did not have that effect. Moreover, research on a different mosquito species, Anopheles arabiensis, shows that IGF-1 actually shortened lifespan in a susceptible strain, indicating that the effect does not apply to all mosquitoes. The claim presents the 23% figure as if it applies to mosquitoes in general, whereas in reality it is tied to one species and one dose.
Too early
“The peptide humanin protects human nerve cells against damage caused by beta-amyloid plaques”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that humanin protects nerve cells against damage caused by beta-amyloid, but this has so far only been demonstrated in laboratory and animal research. One review study describes how humanin protects nerve cells from cell death caused by beta-amyloid in the lab, and animal experiments show that brain damage caused by injected beta-amyloid decreases after humanin is administered. Whether this protective effect also occurs in humans has not yet been tested in studies with actual patients. A few trials with humanin have been registered, but these have not yet produced any results.
✓ Holds up
“Injecting the peptide MOTS-c improves metabolism in mice”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Several mouse studies show that injecting MOTS-c improves metabolism in mice. For instance, injecting the peptide prevents insulin resistance and obesity in mice on a high-fat diet, improves blood sugar regulation in gestational diabetes mice, and increases physical performance in mice of various ages. The claim is specifically about mice, and that is exactly what the research shows, so the claim is correct as formulated.
✓ Holds up
“The peptide GLP-2 stimulates stem cell division and intestinal wall growth in mice”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Several mouse studies show that GLP-2 stimulates stem cell division in the intestinal wall and promotes intestinal wall growth. One study shows that GLP-2 drives stem cells to divide and, with chronic use, increases the number of stem cells per crypt. Another study shows that GLP-2 promotes cell division in the crypts and leads to expansion of the intestinal epithelium. Yet another study shows that treatment with a GLP-2 analogue increased intestinal weight by 28% and was accompanied by larger crypts and longer intestinal villi in mice. The claim is made about mice, and the evidence from mouse studies aligns well with this. → Does GLP-2 help your gut wall repair and grow?
✓ Holds up
“The peptide BPC-157 accelerates healing and improves the function of damaged Achilles tendons in rats.”
David Sinclair (professor of genetics and aging researcher at Harvard Medical School) · Lifespan, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
In animal research, the evidence for BPC-157 is remarkably consistent and positive, and tendon healing in rats fits well within that picture. What animal models show does not always translate to humans: in humans, BPC-157 has barely been studied, and there are no published clinical results. One phase 1 trial for tendon injury is registered but has not yet started and has no published outcomes. The claim about rats is therefore defensible as such, but says little about what you can expect in humans.

Matthew LaPlante

Author and associate professor of journalism at Utah State University

Too early
“Glycine improves recovery after a stroke.”
Matthew LaPlante (Author and associate professor of journalism at Utah State University) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
Research in mice and rats shows that glycine can reduce brain damage after a stroke and promotes neurological recovery. A study in mice also shows that raising glycine levels in the brain reduces stroke-related damage. In humans, however, the evidence is not yet convincing: a large, carefully designed randomised controlled trial did examine a substance that blocks the glycine site on a specific protein in brain cells, but found no effect on the extent of brain damage or patient recovery. The remaining studies in humans also measure outcomes other than stroke recovery. The claim that glycine improves recovery after a stroke has therefore not yet been demonstrated in humans.
Partly
“Metformin inhibits cellular respiration and lowers ATP levels in the cell.”
Matthew LaPlante (Author and associate professor of journalism at Utah State University) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
Metformin does indeed inhibit the energy metabolism of liver cells, which is described as a mild brake on energy production. The fact that its blood sugar-lowering effect works through this mechanism is well supported. Whether metformin also measurably lowers ATP levels at the cellular level goes beyond what the research unambiguously confirms: the precise interplay of all the mechanisms has not yet been fully elucidated. The claim therefore has a kernel of truth, but states the mechanism more categorically than the evidence warrants.
Partly
“Small peptides from collagen are biologically active and can stimulate the production of hyaluronic acid and muscle growth.”
Matthew LaPlante (science journalist, author and associate professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with caution
It is plausible that small peptides from collagen are biologically active, and this is supported by research: there is evidence that collagen peptides can contribute to muscle growth in older adults, particularly in combination with strength training, and it is biologically plausible that they stimulate skin cells. However, for both muscle growth and skin effects there are conditions that the claim leaves out: the effect on muscles is strongest in combination with exercise, and the evidence for skin effects comes almost exclusively from manufacturer-funded research. The specific claim that peptides stimulate the production of hyaluronic acid goes beyond what the available research unambiguously shows.
Partly
“The biological ageing process begins during embryonic development and is influenced by the mother's lifestyle.”
Matthew LaPlante (Professor of journalism at Utah State University, science journalist and author) · Lifespan, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Research shows that ageing processes are indeed already active during embryonic development: in mammals, including humans, programmed cellular senescence occurs in the embryos themselves, and factors such as the mother's weight gain, blood pressure and obesity influence the epigenetic ageing of the placenta. Research also shows that adverse conditions in the womb, such as poor nutrition or exposure to harmful substances, increase the risk of ageing-related diseases later in life. The claim is therefore broadly correct, but "the mother's lifestyle" is somewhat broader than what the studies specifically demonstrate: they focus in particular on weight gain during pregnancy, blood pressure and obesity, not on lifestyle in the wider sense, such as exercise, sleep or stress.
Partly
“Reducing inflammation in the hypothalamus of the brain extends lifespan in laboratory animals.”
Matthew LaPlante (Professor of journalism at Utah State University, science journalist and author) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
Research in mice shows that suppressing inflammation in the hypothalamus is associated with a longer lifespan: mice given life-extending drugs had less hypothalamic inflammation, and that reduction ran parallel to the increase in lifespan. Review studies confirm that hypothalamic inflammation plays a role in ageing and that counteracting it is promising. The claim therefore holds for laboratory animals (mice), but the evidence is largely indirect: studies demonstrate an association and a parallel effect, not a direct manipulation in which only the inflammation was reduced and lifespan was then measured as a result. In humans, this relationship has not yet been tested.
Partly
“Stem cells can donate healthy mitochondria to damaged or ageing body cells.”
Matthew LaPlante (Professor of journalism at Utah State University, science journalist and author) · Lifespan, September 2026 · watch the episode ↗︎ · stated with caution
Several review studies and a pilot study confirm that stem cells can indeed transfer mitochondria to damaged cells, restoring energy production and cell survival. This has been demonstrated in both laboratory and animal research, and studies investigating this in humans are under way. The claim is therefore correct in its general direction, but goes beyond what the evidence firmly supports on two points: the effect has not yet been well demonstrated in humans, and the transfer to specifically 'ageing' cells has not been examined as a separate category in the summaries. Moreover, one review study points out that mitochondrial transfer also has a downside, for example in cancer. → Does stem cell therapy work against ageing in people?
Partly
“Substances such as curcumin, berberine and resveratrol stimulate the production and function of mitochondria and partly act as exercise mimetics.”
Matthew LaPlante (Professor of journalism at Utah State University, science journalist and author) · Lifespan, September 2026 · watch the episode ↗︎ · stated with caution
Exercise demonstrably stimulates the production and function of mitochondria, but the evidence that substances such as curcumin, berberine and resveratrol act as exercise mimetics in humans is not yet solid. Supplements targeting mitochondrial energy metabolism are being actively studied, but show mixed results and lack strong clinical evidence behind them. The claim therefore runs considerably ahead of what the research has shown so far.
Partly
“During ageing, mitochondrial DNA leaks from damaged mitochondria into the cell and bloodstream, causing chronic inflammation because the immune system recognises it as foreign.”
Matthew LaPlante (Professor of journalism at Utah State University, science journalist and author) · Lifespan, September 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Mitochondrial mutations accumulate with ageing and disrupt energy production, while chronic low-grade inflammation and cellular ageing demonstrably reinforce each other. However, the claim that mitochondrial DNA leaks into the bloodstream and is recognised there as foreign by the immune system is a more specific mechanism than the available research supports: the studies cited do not describe the link between mitochondrial damage and inflammation at that level of detail. The broader idea that mitochondrial problems contribute to chronic inflammation during ageing is plausible, but this precise mechanism cannot yet be established on the basis of current research.
Partly
“Catechins from sources such as green tea and cocoa can stimulate the clearance of glycated proteins and lower HbA1c levels.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with caution
The idea that catechins (active compounds in tea and cocoa) influence blood sugar regulation is supported by several large reviews of human clinical studies: catechins from green tea produce a clearly measurable reduction in fasting blood sugar. One such review also shows a small but measurable decrease in HbA1c (a measure of average blood sugar over the preceding months) with the use of catechin preparations, though the researchers themselves consider this effect modest and possibly not meaningful enough to benefit patients. Two other reviews find no measurable effect on HbA1c for green tea as a whole, and cocoa has likewise shown no effect on HbA1c in human studies. The breakdown of already-formed damaged proteins that are bonded to sugar has been demonstrated for certain catechins, but only in the laboratory and in rats, not in humans. The claim thus combines an effect that has so far only been limitedly demonstrated in humans (a reduction in average blood sugar over time) with a mechanism of action (the breakdown of those damaged proteins) that has not yet been studied in humans.
Partly
“Glycine improves collagen production in the body.”
Matthew LaPlante (Author and associate professor of journalism at Utah State University) · Lifespan, September 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Research shows that glycine is one of the most important building blocks of collagen and that a glycine deficiency can inhibit collagen production. Laboratory research with bovine cartilage cells shows that higher glycine levels can improve collagen synthesis, and animal research confirms that the endogenous production of glycine in pigs, chickens and fish is insufficient for maximum collagen production. In humans, this effect of additional glycine on collagen production has not yet been directly demonstrated in studies with actual patients or test subjects. A review article on human research does suggest that insufficient glycine may limit collagen synthesis in connective tissue, but describes this as a hypothesis rather than a proven effect.
Partly
“The peptide GHK binds to copper and supplies the enzyme SOD1 with copper to neutralise free radicals in mitochondria.”
Matthew LaPlante (science journalist, author and associate professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Research shows that GHK does indeed bind copper and that the GHK-Cu complex has antioxidant effects, including raising superoxide dismutase activity. More recent laboratory research also describes how copper can stimulate the production of the enzyme SOD1 via so-called copper chaperones. However, that same lab study also shows that GHK-Cu itself displays no direct superoxide dismutase-like activity, and provides no evidence that GHK specifically delivers copper to SOD1 in mitochondria. The claim goes beyond what research has demonstrated so far: the direct link between GHK, copper delivery to SOD1, and the neutralisation of free radicals in mitochondria has not yet been tested in humans and has only been supported indirectly in the laboratory.
Partly
“Apelin can suppress the secretion of pro-inflammatory substances by senescent cells”
Matthew LaPlante (science journalist, author and associate professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with caution
Research shows that apelin (in particular the variant apelin-13) can indeed reduce the secretion of pro-inflammatory substances by senescent cells, but this has so far only been demonstrated in laboratory and animal research, not in humans. For example, a study using human brain cell lines and a mouse model shows that apelin-13 breaks down a protein that would otherwise produce pro-inflammatory substances, thereby reducing that secretion. Another study in mice and intervertebral disc cells shows a similar effect on inflammatory and ageing processes. The claim is therefore correct in its direction, but the evidence comes exclusively from cell and animal research, while the claim makes no distinction with respect to humans.
Partly
“Physically active people have higher levels of circulating apelin in their blood”
Matthew LaPlante (science journalist, author and associate professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Research in humans paints a mixed picture. A study in middle-aged and older adults found that blood apelin levels rose after eight weeks of aerobic training, and in professional football players apelin rose temporarily after a maximal exercise test. However, a study in obese women found a decrease in apelin after regular exercise, and a seasonal study in professional football players found no meaningful link between apelin levels and athletic performance. One study in obese men found no change in circulating apelin levels at rest after eight weeks of training, despite increased production in muscle tissue. Whether physically active people consistently have higher apelin levels in their blood therefore depends strongly on the target group, the type of exercise and the measurement conditions; a simple yes-or-no statement goes beyond what research has demonstrated so far. → Does exercise raise your apelin levels?
Partly
“The tetrapeptide epithalon can lengthen telomeres and possibly extend lifespan”
Matthew LaPlante (science journalist, author and associate professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with caution
Research shows that epithalon can lengthen telomeres in human cells studied and cultured in the laboratory, and a review study confirms that this effect is biologically plausible because the substance activates the enzyme telomerase. However, the claims that epithalon makes people live longer have not yet been proven: the only available review study concludes that epithalon has not been clinically demonstrated, that no well-designed randomised controlled trials in humans have been conducted, and that safety data for long-term use are lacking. Telomere lengthening in laboratory research with cultured cells has thus been demonstrated, but whether this also leads to a longer or healthier lifespan in humans remains an open question at this time. → Can you lengthen or restore your telomeres?
Partly
“Eating too much animal protein rich in branched-chain amino acids overstimulates mTOR and suppresses the body's own protective mechanisms against ageing.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with caution
mTOR is indeed a central switch that drives cells to grow, and chronic overactivation contributes to ageing; autophagy, one of the body's protective mechanisms, also declines when mTOR is overactive. However, the research in our sources focuses on excessive mTOR activity in general, not specifically on animal protein or branched-chain amino acids as the culprit. Whether you can genuinely slow ageing by eating less animal protein has not yet been proven in humans; the best-supported ways to keep mTOR in check are eating less and exercising more.
Partly
“A poor diet can increase inflammation and blood sugar levels, alter the gut microbiome, and accelerate ageing.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
The direction of the claim is correct: an unhealthy diet is associated with chronic inflammation, disruptions to the gut microbiome, and accelerated cellular ageing. This association has been demonstrated consistently across multiple studies, although the research is largely observational and mechanistic rather than establishing a firm chain of cause and effect. The available studies say little about blood sugar levels as a separate consequence of a poor diet, so that part of the claim is less well supported. The claim is therefore broadly accurate, but comes across as somewhat more definitive than the moderate evidence warrants.
✗ Does not hold up
“Activating sirtuins through exercise, fasting or molecules such as resveratrol improves the functioning of other nutrient sensors such as mTOR and AMPK.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
The claim states that sirtuins, activated through exercise, fasting, or resveratrol, improve the functioning of mTOR and AMPK, but the research paints a different and more nuanced picture. Sirtuins may influence ageing processes in animal and laboratory studies, but convincing human data are entirely lacking. Moreover, exercise and fasting are themselves the direct activators of AMPK, while mTOR is actually suppressed by reduced food intake and exercise rather than "improved" via sirtuins. The proposed relationship, in which sirtuins act as an intermediary that upgrades the functioning of mTOR and AMPK, is not supported by the available research.
Partly
“Metformin improves insulin sensitivity and stimulates mitochondrial activity through mechanisms such as AMPK.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
Metformin does indeed work through multiple interrelated mechanisms, including effects on cellular energy balance that are linked to AMPK. However, the picture is more nuanced than the claim suggests: at normal doses, disruptions in energy balance and inhibition of a specific liver enzyme play the greatest role, while the mitochondrial respiratory chain only appears to become relevant at higher concentrations. The claim that metformin improves insulin sensitivity is correct as a general direction, but the primary effect is the suppression of glucose production in the liver, not a direct improvement of insulin sensitivity as the main mechanism. Moreover, exactly how the various mechanisms interact has not yet been fully worked out.
Partly
“As we age, the diversity of the gut microbiome decreases and shifts occur towards pro-inflammatory bacterial species.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
Multiple human studies confirm that the gut flora changes with age and that a diverse flora is associated with healthier ageing. The first part of the claim, a decrease in diversity, is supported by observational research. The second part, a shift towards specifically pro-inflammatory bacterial species, goes a step further than the available evidence firmly establishes: the research is largely associative and shows rather a reduction in anti-inflammatory species than a proven increase in harmful ones. Furthermore, cause and effect have not yet been demonstrated.
Partly
“Chronic low-grade inflammation accelerates cellular ageing and contributes to conditions such as diabetes, heart disease and Alzheimer's disease.”
Matthew LaPlante (Author, journalist and university lecturer in journalism) · Lifespan, September 2026 · watch the episode ↗︎ · stated with confidence
The link between chronic low-grade inflammation and accelerated cellular ageing is well established and consistent with the research evidence. The association with diabetes and cardiovascular disease is also supported by multiple studies. For Alzheimer's disease, however, the connection is biologically plausible but causal evidence in humans has not yet been fully demonstrated. The claim is therefore largely correct, but presents the evidence for all three conditions as equally strong, whereas the evidence for dementia is less robust than it is for diabetes and heart disease.

Steve Horvath

Mathematician, biostatistician and pioneer in epigenetic aging clocks

Partly
“The epigenome and DNA methylation play an active role in the ageing process itself and do not merely act as a timekeeper”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research supports the idea that epigenetic dysregulation plays a role in the ageing process: ageing proceeds in part through epigenetic dysregulation, and this is described as one of a set of interconnected mechanisms. However, the claim goes further by asserting that the epigenome and DNA methylation actively drive the process rather than merely recording it. Whether methylation patterns genuinely drive ageing or primarily reflect it is a distinction that available research in humans cannot yet draw clearly. The direction of the claim is plausible, but that specific causal role has not yet been demonstrated.
Partly
“Cycling four and a half hours a week can lower biological age as measured by the GrimAge clock by about six months.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with caution
Research in humans does indeed show that more physical activity is associated with a lower biological age on the GrimAge clock. A pilot study with 38 adults who cycled for six months found an average reduction of just over seven months on the GrimAge clock. The claim of "about six months" falls within that ballpark, but this was a small pilot study in which overall fitness also improved significantly, making it more than just four and a half hours of cycling per week as a standalone measure. Larger reviews and other studies measure the relationship in statistical units and do not translate it into a fixed number of hours of cycling, and most studies are cross-sectional, which does not establish a causal relationship. The specific combination of "four and a half hours per week" and "six months" has not been established in this precise way by research.
Partly
“Sun-induced skin damage accelerates the epigenetic ageing of the skin.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that UV exposure can measurably increase the biological age of the skin, and that the skin, due to its sensitivity to external stimuli such as sunlight, ages biologically faster than internal organs. That this occurs specifically via epigenetic ageing is not firmly established in the available evidence: the studies point to visible damage such as wrinkles, age spots and collagen loss, but do not explicitly link this to epigenetic clocks. The direction of the claim is plausible, but the precise epigenetic pathway has not yet been demonstrated in humans.
Partly
“TET enzymes, which remove DNA methylation, are necessary to bring about cellular rejuvenation.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · repeated in November 2026 · stated with confidence
Research in mouse cells and mouse embryos shows that TET enzymes play an essential role in epigenetic reprogramming: without these enzymes, it is not possible, for example, to reprogram ordinary body cells back into stem cells. However, the studies deal exclusively with reprogramming to pluripotency (resetting cells to a stem cell-like state) or with early embryonic development, not with cellular rejuvenation in the broader sense as intended in the context of healthy ageing. Moreover, several studies indicate that the process is more complex than simply removing DNA methylation, and that TET proteins also work in other ways. In humans, the necessity of TET enzymes for rejuvenation has not yet been tested.
✗ Does not hold up
“Less than 20 percent of how long someone lives is genetically determined.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with caution
Several twin studies in humans show that the heritability of lifespan ranges from 7% to above 50%, depending on the method used and the population studied. A recent 2026 study shows that earlier low estimates (20–25% in twin studies, or even 6% in large family tree studies) are biased because they include people who die young due to accidents or infections. When you correct for this, the heritability of 'intrinsic' lifespan comes out at more than 50%. The claim that genes determine less than 20% is therefore inconsistent with what this research shows: the actual estimate depends strongly on how you measure it, and in several studies it is considerably higher. → Do I inherit my life expectancy from my parents?
Partly
“Smoking and metabolic stress from diabetes or obesity accelerate epigenetic ageing.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
For overweight and diabetes, there is consistent evidence that they accelerate biological ageing, as reflected in epigenetic clocks and telomere length. The claim goes slightly beyond the available evidence when it comes to smoking: direct confirmation is lacking in the research, while the evidence for the metabolic factors is largely observational and cause and effect cannot always be separated. The direction of the claim is therefore partially correct, but smoking as a contributing factor cannot be substantiated on the basis of what the research shows.
✓ Holds up
“An HIV infection increases epigenetic age.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Several review studies in which researchers summarised all available research, and a study in which the results of multiple studies were combined statistically, show in humans that an HIV infection is associated with accelerated epigenetic ageing. The combined analysis of 14 studies found an average difference of 3.41 years in epigenetic age between people with and without HIV. A study in which the same individuals were followed over a longer period also showed that this acceleration already occurs around the time of the initial infection. The claim is therefore well supported by research in humans, although the review studies emphasise that the individual studies are relatively small and use different measurement methods.
Partly
“By analysing DNA methylation in a saliva sample, a person's biological age can be determined.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
DNA methylation in saliva can indeed be used to estimate someone's biological age, and the models are reasonably well supported for scientific and forensic use. However, saliva and blood do not yield the same results, and for personal use the validation is still too limited. Moreover, such a test measures your chronological age more than your biological age in the broader sense: whether the score also says something about how quickly your body is ageing has not yet been well established.
Partly
“Pregnancy temporarily accelerates epigenetic ageing, but this effect reverses afterwards.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research in humans does show that biological age measurably accelerates during pregnancy. One prospective study of pregnant women found an acceleration of epigenetic age of just over one to just over five years compared to non-pregnant women. A larger study in both mice and humans confirms that biological age temporarily rises under stress such as pregnancy, and that it recedes again after recovery. However, full recovery after childbirth has not been conclusively demonstrated in humans: the study describing the recovery period after pregnancy states that the acceleration only partially reverses and that, if a subsequent pregnancy occurs before full recovery, the effects can accumulate. The claim that the effect "reverses afterwards" therefore goes somewhat further than what the studies show with certainty.
Partly
“Based on DNA methylation, the biological age of most human tissues and cell types can be accurately estimated.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Epigenetic clocks based on DNA methylation can indeed estimate biological age, and those estimates demonstrably correlate with disease and mortality in population studies. However, "accurately" is a stronger claim than the evidence supports: commercial models often perform worse than promised due to methodological shortcomings, and whether the clock performs equally well in every tissue and cell type has not yet been firmly established. The technology is scientifically credible, but accuracy varies by application and has not yet been independently validated for all those tissues.
Too early
“An extracellular matrix derived from young cells can rejuvenate old cells.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Research shows that a young cell scaffold, the natural structure in which cells live and grow in the body, can rejuvenate aged cells, but this has so far been demonstrated almost exclusively in the laboratory and in animals. One study shows, for example, that human skin cells from older individuals display fewer signs of ageing when exposed to such a young cell scaffold derived from pigs, and in mouse heart tissue a young cell scaffold appears to keep heart cells in a calmer, less aged state. Studies are still limited to laboratory research and animal trials, however, and the five registered clinical trials in humans have produced no published results. Whether this effect also works in living humans has therefore not yet been demonstrated.
Partly
“DNA methylation predicts the risk of disease and premature death.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
In population studies, epigenetic clocks are indeed associated with mortality and disease, so the direction of the claim is correct. However, the claim goes further than the evidence justifies: whether DNA methylation also predicts reliably at the individual level has not yet been demonstrated. Commercial tests also frequently perform worse than promised due to methodological shortcomings, and it is unclear whether a personal score changes when someone adopts a healthier lifestyle.
✓ Holds up
“Second-generation epigenetic clocks, such as GrimAge and PhenoAge, can predict the risk of premature death.”
Steve Horvath (Mathematician, biostatistician and pioneer in epigenetic aging clocks) · Lifespan, November 2026 · watch the episode ↗︎ · stated with confidence
Second-generation clocks such as GrimAge and PhenoAge do indeed predict mortality and serious disease better than their earlier counterparts. Research shows that GrimAge responds reliably to factors such as BMI and insulin resistance, and that PhenoAge measures health risks through standard blood values that calendar age alone cannot capture. However, the biology underlying the scores has not yet been fully elucidated, and for individual use the uncertainty is greater than commercial providers sometimes suggest.

Dr. Matthew LaPlante

Co-author and journalist/professor

✗ Does not hold up
“Ketones help maintain reaction accuracy during prolonged, mentally demanding exertion.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · repeated in September 2026 · stated with confidence
Research on ketone drinks in healthy people shows no benefit for brain performance; in fact, in physical exertion, efficiency worsens in several studies. It has not been demonstrated that ketones specifically help maintain reaction accuracy during prolonged, mentally demanding exertion. The positive indications that do exist apply to people with mild memory problems, not to healthy people in a physical exertion context.
Partly
“GLP-1 agonists are associated with a 30% lower incidence of breast cancer in women between the ages of 45 and 80.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Several large observational studies do indeed show that women who use GLP-1 drugs develop breast cancer somewhat less often. The direction of the claim is therefore correct. However, the stated percentage of 30% is not precisely accurate: the largest study, conducted in women aged 45 to 80 with excess weight, did find a risk reduction of around 30% after statistical adjustment to make the groups comparable, but other large studies find smaller reductions or no clearly measurable effect on breast cancer at all. Randomised controlled trials, which are considered the most reliable form of evidence, have so far shown little to no effect on breast cancer risk. The claim presents the 30% as an established fact, whereas the figures vary considerably between studies and the evidence still comes mainly from observational research.
Partly
“The aging brain's ability to use ketones remains largely intact, despite a decline in glucose use.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Several review studies in humans confirm that glucose use by the aging brain declines, and that the brain can use ketones as an alternative fuel. This forms the basis for ketogenic therapeutic strategies in age-related conditions such as Alzheimer's disease. The claim is therefore broadly correct. However, the studies do add nuance: one study explicitly points out that aging is accompanied by a loss of metabolic flexibility, meaning the brain becomes less able to switch between different energy sources, including ketones. The claim that ketone use remains 'largely intact' therefore goes slightly further than what the studies consistently demonstrate.
✓ Holds up
“Beta-hydroxybutyrate (BHB) acts as an epigenetic regulator for immune T cells.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Several studies show that BHB brings about epigenetic changes in various types of T cells. Research demonstrates that BHB chemically modifies histones in memory T cells, thereby steering memory formation, and that in effector cells it rewrites genes through changes in histone acetylation. A similar epigenetic mechanism is also described for Treg cells in mice. A study with healthy volunteers furthermore shows that BHB supplementation has measurable effects on T cells in humans. The claim that BHB acts as an epigenetic regulator for immune T cells is thus broadly supported by the research, although the precise mechanisms and effects differ between T cell types.
✓ Holds up
“GLP-1 receptor agonists extend lifespan and improve healthspan in older female mice.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
A study in 20-month-old female mice of a specific laboratory strain shows that treatment with semaglutide extended lifespan and improved several measures of healthy ageing, including memory, motivation to move and blood sugar regulation. The claim focuses specifically on older female mice, which is precisely what this study investigated. A second mouse study confirms that continuous treatment with this drug benefits metabolism, while repeatedly stopping the treatment reverses the effects. This effect has not yet been studied in humans, but the claim does not assert that either. → Do GLP-1 medications (such as Ozempic) help you age more healthily?
Partly
“Semaglutide slowed the rate of ageing by 9% in patients, according to a study.”
Dr. Matthew LaPlante (Co-author and journalist/professor) · Lifespan, October 2026 · watch the episode ↗︎ · stated with confidence
Semaglutide did indeed show a measurable slowing of biological aging in research, but the study it is based on was small, conducted in HIV patients, and not primarily designed to measure aging. The figure of 9% cannot be substantiated: the effects found were expressed as a difference of two to five years on aging clocks, not as a percentage of the rate of aging. Whether this result also applies to people without HIV has not yet been tested.

Dr. David Sinclair

Professor of genetics and aging researcher at Harvard Medical School

Partly
“Epigenetic reprogramming using three Yamanaka genes (OSK) can help damaged retinal nerve cells restore their youthful functions.”
Dr. David Sinclair (Professor of genetics and aging researcher at Harvard Medical School) · Lifespan · watch the episode ↗︎ · stated with caution
Our answer on epigenetic reprogramming confirms that animal and cell culture studies show that ageing patterns can be reversed, which supports the direction of the claim. Research on retinal nerve cells in animal models fits within that broader picture. Nevertheless, the claim goes further than the available evidence justifies: evidence in humans is entirely lacking, and the biggest unresolved problem remains safety, as excessive reprogramming increases the risk of tumour formation. The claim sounds more definitive than the current state of research allows.

From the episodes, no speaker named

Partly
“Exercising intensely within 4 hours before bedtime disrupts sleep quality and increases the time it takes to fall asleep.”
Lifespan · watch the episode ↗︎ · stated with confidence
Intense exercise less than four hours before bedtime is indeed associated with falling asleep later, shorter sleep duration and a higher nocturnal heart rate. That said, the claim goes slightly too far: well-trained athletes appear to be considerably less affected by this, so the effect is not equally strong for everyone. The four-hour safety margin is well-supported, but whether it also increases the time it takes to fall asleep for every athlete is less certain than the claim suggests.
✗ Does not hold up
“In inactive adults, every hour of walking yields an estimated 6.3 hours of extra life expectancy.”
Lifespan · watch the episode ↗︎ · stated with confidence
Research shows that regular walking is associated with two to six extra years of life, with the greatest gains for people who are currently barely active. The figure of 6.3 hours of extra life expectancy per hour of walking does not appear in the available evidence and cannot be substantiated. The direction is right, but this specific figure goes beyond what the research supports.
Partly
“One to two strength training sessions per week are already associated with a significantly lower mortality rate.”
Lifespan · watch the episode ↗︎ · stated with confidence
The finding that strength training is associated with a lower risk of death is consistent with what research shows: people who exercise for 150 to 300 minutes per week and combine this with muscle-strengthening exercises see the most favourable picture. However, the claim that one to two sessions per week already make a "significant" difference to mortality goes beyond what the evidence firmly supports. The research supports the transition from inactive to active as the largest gain, but attaching a specific mortality figure to one or two strength training sessions per week cannot be firmly established on the basis of this research.
Partly
“Playing racket sports such as tennis or squash is associated with a 47% lower risk of dying from all causes compared to non-practitioners.”
Lifespan · watch the episode ↗︎ · stated with confidence
Tennis is linked to a longer life expectancy in several large studies, and a Copenhagen study found that tennis offered the greatest gain of all the sports examined. The specific figure of a 47% lower risk of death from all causes does appear in that Copenhagen study and is consistent with what the available research shows, but comparable evidence is lacking for squash. The claim suggests that it applies equally to both sports, whereas the evidence for squash is not available. The claim can be supported for tennis, but not for racket sports as a category as a whole.
Partly
“Each point higher on the sitting-rising test (SRT) is associated with a reduction of about 21% in the risk of dying from all causes.”
Lifespan · watch the episode ↗︎ · stated with confidence
A low SRT score is indeed associated with a significantly higher risk of death, and this association has been demonstrated in research. However, the precise figure of 21% per point cannot be firmly established on the basis of the available evidence; moreover, the claim goes beyond what the research supports: it concerns a statistical association, not a proven causal relationship. The score reflects your overall physical condition, but whether improving it directly reduces your risk of death has not yet been directly demonstrated.
Partly
“Heavy impact strength training increases bone density in the hip and spine of postmenopausal women with osteopenia or osteoporosis.”
Lifespan · watch the episode ↗︎ · stated with confidence
Intensive strength training measurably increases bone density in people with low bone mass, and high training intensity appears to yield the greatest benefit. The claim goes beyond the evidence on two points: that specifically 'impact' training makes the decisive difference cannot be substantiated, and that bone density of both the hip and the spine increases in postmenopausal women with osteopenia or osteoporosis has not yet been established in randomised studies. Furthermore, it has not been proven that strength training reduces the number of fractures.
Partly
“The maximum reduction in mortality risk is achieved at 2.5 to 5 hours of vigorous physical activity or 5 to 10 hours of moderate physical activity per week.”
Lifespan · watch the episode ↗︎ · stated with confidence
Exercising more does reduce your risk of dying, and the benefit levels off beyond a certain amount, but the specific thresholds mentioned in the claim do not match what the research shows. The available evidence points to 450 to 750 minutes of moderate activity per week as the point at which further gains diminish, not the 300 to 600 minutes (5 to 10 hours) the claim suggests. The direction is correct, but the precise range of 2.5 to 5 hours of vigorous activity or 5 to 10 hours of moderate activity as the optimum for maximum risk reduction is not supported by the research.
Partly
“Twelve weeks of yoga combined with meditation reduces biomarkers of DNA damage and inflammation (such as 8-oxodG and IL-6) and increases telomerase activity.”
Lifespan · watch the episode ↗︎ · stated with confidence
There are tentative indications that meditation programmes can increase telomerase activity, and an effect on inflammatory markers through stress reduction is plausible. However, the step to specific biomarkers such as 8-oxodG and IL-6, after exactly twelve weeks of yoga combined with meditation, goes beyond what the available research supports. The studies showing positive signals are small and vary in design, and whether yoga as an addition makes a difference over meditation alone has not been demonstrated. The direction of the claim is not implausible, but the combination of specific biomarkers, a precise duration, and the pairing of yoga with meditation has not yet been convincingly tested.
Partly
“From around the age of 40, people lose roughly 2 to 4% of their muscle power every year.”
Lifespan · watch the episode ↗︎ · stated with confidence
Research does show that muscle strength declines significantly after middle age, but the findings specifically point to a loss of 3 to 4% per year in leg strength after the age of fifty, not 2 to 4% already from the age of forty. Furthermore, this refers to strength, whereas the claim speaks of muscle power, which is a subtly different concept. The direction of the claim is correct, but the starting age and the precise percentage differ from what the research shows.
Partly
“Every increase in resting heart rate of 10 beats per minute is linked to a 15 to 20% increase in the risk of death from all causes.”
Lifespan · watch the episode ↗︎ · stated with confidence
A higher resting heart rate is indeed associated with an increased risk of death, and this relationship has been demonstrated independently of other risk factors. The direction of the claim is therefore correct. However, the precise figure of 15 to 20% per 10 beats per minute cannot be firmly established on the basis of available research: studies do show an elevated risk above certain thresholds, but a quantified linear relationship of this precision per increment of 10 beats has not been established. Moreover, research suggests that a very low resting heart rate in older age is not necessarily a good sign either, which makes the relationship less straightforward than the claim implies.
Partly
“As little as 75 minutes of moderate exercise per week (about 11 minutes a day) significantly reduces the risk of premature death and cardiovascular disease.”
Lifespan · watch the episode ↗︎ · stated with confidence
Research shows that the greatest health gains begin with even a modest amount of physical activity, so the direction of the claim is correct. However, the studies in our knowledge base use 150 minutes per week as the reference point for a significant reduction in mortality risk, not 75 minutes. Whether that halved amount is already sufficient for a measurable benefit on both premature death and cardiovascular disease cannot be firmly established based on the available evidence.
Partly
“The lowest mortality risk is observed in people who exercise between 2.5 and 4.5 hours per week, while more than 10 hours per week is associated with a higher risk again.”
Lifespan · watch the episode ↗︎ · stated with confidence
Research does indeed show that more physical activity lowers the risk of death, but that the gains diminish as you do more. That aligns with the direction of the claim. However, the specific ranges mentioned (2.5 to 4.5 hours, and more than 10 hours as risk-increasing) cannot be substantiated based on the available research: studies suggest the point at which benefits level off is closer to 450 to 750 minutes per week, and an increased mortality risk above 10 hours has not been demonstrated. That overtraining can be harmful is documented, but this applies to elite athletes who train extremely hard without adequate recovery, not to an increased mortality risk from recreational exercise of more than 10 hours per week.
Newsletter

Stay in the loop

Every Thursday, the most important longevity research in your inbox, focused on what you follow.